Osteoporosis
Fracture risk reduction with teriparatide is independent of pretreatment bone turnover
Published in Women's Health Weekly, August 31st, 2006
Scientists in France report, "Teriparatide is a bone formation agent that increases bone turnover and mass, resulting in an increase in bone strength and a decrease in fracture risk. The primary purpose of this analysis was to evaluate the association between pretreatment bone turnover marker (BTM) concentrations and the absolute and relative fracture risks after adjusting for baseline femoral neck BMD, number of prevalent vertebral fractures, and age."
P.D. Delmas and colleagues of Claude Bernard University of Lyon stated, "Because femoral neck BMD is...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- Breast Cancer
Breast cancer risk is associated with postmenopausal weight changes - Breast Cancer
Number of biopsies of MR lesions may be reduced by use of exam interpretation software - Coronary Artery Disease
Breast arterial calcification may predict increased coronary disease risk in healthy women - HIV/AIDS Therapy
HIV-positive women on antiretroviral therapy may have increased risk of atherosclerosis - Heart Disease
Raloxifene does not affect risk of cardiovascular events in postmenopausal women - Anesthesia
Hysterosalpingography with paracervical anesthetic block produces less discomfort - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
